Detection of Biomarkers for Prosthetic Infection Type - (DEBIT)
Sponsor: Portsmouth Hospitals NHS Trust • ClinicalTrials.gov ID: NCT07838064
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Prosthetic joint infection (PJI) is a significant cause of failure in hip and knee arthroplasty and is often difficult to diagnose using current methods. This study aims to identify novel biomarkers for early and accurate diagnosis of PJI using nanopore sequencing technology (Oxford Nanopore Technologies). By analysing microbial profiles and host immune responses in samples from patients undergoing revision surgery, the study will compare infected and non-infected cases. Biomarkers will be investigated in periprosthetic tissue as well as less invasive sample types, including synovial fluid and blood, with the goal of improving early diagnosis and guiding future treatment strategies.
Interventions
-
Prosthetic joint replacement
(Procedure)
Primary joint replacement
Eligibility criteria
Conditions
Locations
- Queen Alexandra Hospital — Portsmouth, United Kingdom
- Southampton General Hospital — Southampton, United Kingdom
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record